Barcelona, Spain

Concepcion Gonzalez


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1993-1998

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Concepcion Gonzalez - Innovator in Angiotensin II Antagonists

Introduction

Concepcion Gonzalez, a prolific inventor based in Barcelona, Spain, is recognized for his significant contributions to pharmaceuticals, particularly in the field of angiotensin II antagonists. With a total of four patents to his name, Gonzalez has made remarkable strides in medical research and drug development.

Latest Patents

Among his latest inventions, Gonzalez has developed pyrazole derivatives and imidazopyridine derivatives, both serving as angiotensin II antagonists. The imidazopyridine derivatives, in particular, feature a complex chemical structure designed to target specific physiological mechanisms. His innovations continue to pave the way for advancements in hypertension treatment.

Career Highlights

Throughout his career, Gonzalez has made an impact while working for notable companies such as J. Uriach & Cia. His work has emphasized the development of effective therapies based on sound scientific principles, demonstrating his commitment to improving patient health outcomes.

Collaborations

Gonzalez has collaborated with talented individuals in the industry, including Carmen Almansa and Elena Carceller. These partnerships reflect his dedication to teamwork and innovation within the research community, allowing for the exchange of ideas and expertise.

Conclusion

Concepcion Gonzalez's contributions to the field of pharmaceutical sciences exemplify the vital role of inventors in advancing healthcare. His inventions and collaborative efforts continue to have a lasting impact, ensuring that patients receive the benefits of innovative treatment options. Through his commitment to excellence, Gonzalez stands out as a leading figure in the realm of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…